JACOB WALL: Open Payments
NPI 1932770005 · GREENWOOD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$400 in 33 payments from 11 companies in 2025. Trend: 2023 $157 · 2024 $378 · 2025 $400
Food & beverage: $400
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $171 |
| Incyte Corporation | 3 | $49 |
| UCB, Inc. | 2 | $32 |
| Janssen Biotech, Inc. | 1 | $25 |
| Galderma Laboratories, L.P. | 1 | $24 |
| Lilly USA, LLC | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Arcutis Biotherapeutics, Inc. | 1 | $16 |
| Amgen Inc. | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: RINVOQ, OPZELURA, SKYRIZI, Bimzelx, DUPIXENT, TREMFYA, NEMLUVIO, TALTZ.
Industry payments across IN — which companies pay providers there.
